{"corpus_id":9964821,"paper_sha":"bb31a1781805d3438d7923f72b1865dcfe78d9ca","doi":"10.1186/1758-5996-4-50","arxiv_id":null,"pmid":23199230,"pmcid":"3538575","mag_id":2144943311,"dblp_id":null,"acl_id":null,"title":"Insulin use, prescription patterns, regimens and costs.-a narrative from a developing country","year":2012,"publication_date":"2012-12-02","venue":"Diabetology & Metabolic Syndrome","journal":{"name":"Diabetology & Metabolic Syndrome","pages":"50 - 50","volume":"4"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle"],"pubmed_pub_types":["Journal Article"],"s2_fields_of_study":["Medicine"],"reference_count":21,"citation_count":48,"influential_citation_count":3,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":null,"chemicals":null,"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"https://dmsjournal.biomedcentral.com/counter/pdf/10.1186/1758-5996-4-50","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/bb31a1781805d3438d7923f72b1865dcfe78d9ca","s2_open_access_license":"CCBY","s2_open_access_status":"GOLD","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"BackgroundAchieving good glycemic control is of paramount importance in the reduction of diabetes mellitus (DM) associated morbidity and mortality. Insulin plays a key role in the management of DM but unfortunately whilst some healthcare providers present insulin as a treatment of last resort , patients on insulin often have insulin related issues such as needle phobias, fear of hypoglycaemia, weight gain and in developing countries, costs. This Report aims at assessing insulin prescription pattern, insulin costs and issues associated with adherence.MethodsThis was a Cross-sectional observation Study whereby 160 patients with DM who were on insulin solely or in combination with oral hypoglycaemic agents were recruited over a 6 month period. Information obtained from the Study subjects pertained to their histories of DM, types of insulin, insulin costs, adherence issues and insulin delivery devices. Long and short term glycaemic control were determined and evaluated for possible relation to insulin adherence. Test statistics used were chi square, t test and binary regression.ResultsInsulin adherence was noted in 123-77% of the Study subjects and this was comparable between persons with type 1 DM and those with type 2 DM. The mean glycosylated haemoglobin values were significantly higher in those who admitted to non insulin adherence compared to those who adhered to their insulin regimen (9.7% (2.3) Vs 8.6% (2.1), p = 0.01). Reasons proffered by Respondents for non insulin adherence included high costs-15(41%), inconvenience −15 (41%) and needle pain-79)18%. A greater proportion of persons who self injected insulin adhered to insulin prescriptions compared to those who did not self inject and thus had better glycaemic control. Shorter duration of DM and older age were found to be predictors of adherence to insulin prescription.The monthly mean costs of insulin for those who earned an income was 5212.8 Nigerian naira which is equivalent to 33.1 US dollars and we estimated that persons on a minimum wage would spend 29% of their monthly income on the procurement of insulin.ConclusionsHealth related costs, age, duration of DM and insulin associated side effects are some of the factors implicated in adherence to insulin prescription.","claims":[{"public_id":"cl_e2344303984fcef9cb20e7ac7307814b","status":"active","text":"High costs, inconvenience, and needle pain were the main reasons reported for nonadherence to insulin.","confidence":0.93,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_e2344303984fcef9cb20e7ac7307814b"},{"public_id":"cl_d7df2355ad52654d2bf7e5029c73c144","status":"active","text":"Insulin adherence was 77% among the 160 patients, and adherence was comparable between type 1 diabetes mellitus and type 2 diabetes mellitus.","confidence":0.97,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_d7df2355ad52654d2bf7e5029c73c144"},{"public_id":"cl_2e55b2aacef60c0a76b098bc305b6461","status":"active","text":"Nonadherence to insulin was associated with higher mean glycated hemoglobin values than adherence, indicating worse glycemic control.","confidence":0.95,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_2e55b2aacef60c0a76b098bc305b6461"},{"public_id":"cl_0ccaf9839a9654cab81e7512d5e09554","status":"active","text":"Self-injection of insulin was associated with better adherence and better glycemic control than not self-injecting.","confidence":0.9,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_0ccaf9839a9654cab81e7512d5e09554"},{"public_id":"cl_fc5b7b453f2cfc5caf02174611824976","status":"active","text":"Shorter duration of diabetes mellitus and older age were predictors of adherence to insulin prescription.","confidence":0.92,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_fc5b7b453f2cfc5caf02174611824976"},{"public_id":"cl_c0f0f0d42f08a3b0b04dd7f1abc633ab","status":"active","text":"The mean monthly insulin cost among income earners was 5212.8 Nigerian naira, about 33.1 US dollars, and minimum-wage earners would spend an estimated 29% of their monthly income on insulin.","confidence":0.98,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_c0f0f0d42f08a3b0b04dd7f1abc633ab"}],"concepts":[{"public_id":"co_054de155feb8b0373cbc85c264ee6ca6","status":"active","name":"needle pain","description":"Pain or discomfort associated with insulin injection needles.","types":["side effect","barrier"],"aliases":["needle phobia"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_054de155feb8b0373cbc85c264ee6ca6"},{"public_id":"co_0c12d02460baa7883531a5336941969f","status":"active","name":"glycemic control","description":"The degree to which blood glucose levels are kept within target range.","types":["outcome"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_0c12d02460baa7883531a5336941969f"},{"public_id":"co_29c618808c9d1c737ebec27a25ce85bf","status":"active","name":"type 1 diabetes mellitus","description":"A form of diabetes mellitus characterized by absolute insulin deficiency.","types":["condition"],"aliases":["type 1 DM"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_29c618808c9d1c737ebec27a25ce85bf"},{"public_id":"co_3e12e302e236a363d0082485dd3489d9","status":"active","name":"monthly insulin cost","description":"The average monthly amount spent on insulin by patients in the study setting.","types":["measurement"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_3e12e302e236a363d0082485dd3489d9"},{"public_id":"co_50b9b381654edfc80efe55a6a1528bd3","status":"active","name":"type 2 diabetes mellitus","description":"A form of diabetes mellitus characterized by insulin resistance and relative insulin deficiency.","types":["condition"],"aliases":["type 2 DM"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_50b9b381654edfc80efe55a6a1528bd3"},{"public_id":"co_5d832dd535f1afae48978815383ff377","status":"active","name":"glycated hemoglobin","description":"A blood marker used to assess longer-term glycemic control.","types":["measurement"],"aliases":["HbA1c"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_5d832dd535f1afae48978815383ff377"},{"public_id":"co_6be7e5f31aa84efe82be7fcc5ac5fa33","status":"active","name":"older age","description":"Higher patient age as a demographic factor examined as a predictor of adherence.","types":["predictor"],"aliases":["age"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_6be7e5f31aa84efe82be7fcc5ac5fa33"},{"public_id":"co_98a2915889aca4556a92b88a86791127","status":"active","name":"duration of diabetes mellitus","description":"The length of time a patient has had diabetes mellitus.","types":["predictor"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_98a2915889aca4556a92b88a86791127"},{"public_id":"co_9cd610bb881d9e5ab980ddc50927f6e4","status":"active","name":"insulin adherence","description":"The extent to which patients follow their prescribed insulin regimen.","types":["outcome"],"aliases":["adherence to insulin prescription","insulin prescription adherence"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_9cd610bb881d9e5ab980ddc50927f6e4"},{"public_id":"co_a67509b6b6fc6d672415c494a2f18f78","status":"active","name":"self-injected insulin","description":"Insulin administered by the patient rather than by another person.","types":["delivery method"],"aliases":["self inject"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_a67509b6b6fc6d672415c494a2f18f78"},{"public_id":"co_aa64fcf2d0d17b93cc4720127a22cda8","status":"active","name":"high insulin costs","description":"The financial burden of purchasing insulin reported by patients as a barrier to use.","types":["barrier"],"aliases":["high costs"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_aa64fcf2d0d17b93cc4720127a22cda8"},{"public_id":"co_b16ab2152072d319bd2e6c44278ab10d","status":"active","name":"Nigerian naira","description":"The local currency used to report insulin costs.","types":["currency"],"aliases":["naira"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_b16ab2152072d319bd2e6c44278ab10d"},{"public_id":"co_e8662d04e0aea981702aeaf0da5b30c1","status":"active","name":"minimum wage","description":"The lowest wage level used here to estimate the share of income spent on insulin.","types":["economic measure"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_e8662d04e0aea981702aeaf0da5b30c1"},{"public_id":"co_eae6e5d779ed1d61f33425e7afa1edc4","status":"active","name":"inconvenience","description":"Practical difficulty or burden associated with following the insulin regimen.","types":["barrier"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_eae6e5d779ed1d61f33425e7afa1edc4"}],"external_ids":{"DOI":"10.1186/1758-5996-4-50","ArXiv":null,"PubMed":23199230,"PubMedCentral":"3538575","MAG":2144943311,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://dmsjournal.biomedcentral.com/counter/pdf/10.1186/1758-5996-4-50","landing_url":"https://www.semanticscholar.org/paper/bb31a1781805d3438d7923f72b1865dcfe78d9ca","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":"CCBY","status":"GOLD","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":638228,"paper_uid":"0dcc468b-1e40-4c92-a744-fe669e3a5aef","canonical_identity":{"paper_id":638228,"paper_uid":"0dcc468b-1e40-4c92-a744-fe669e3a5aef","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/9964821"}